7. Replacement G2 Solenoid Assembly EBV145A SO1134R 8. Replacement G2 Sensor Eye (Urinal) EL1500 SO1122 Replacement G2 Sensor Eye for (Toilet) EL1500L SO1123 9.Replacement Solenoid Operator Only EBV136A SO1134R 0.25 GPF for Urinal A1047A SO1076G 8. G2 Sensor Eye 6. G2 Optima...
2109113 ST-9113-A 1101000 SU-1000-A 1101002 SU-1002-A 1101005 SU-1005-A 1101006 SU-1006-A 1101010 SU-1010-A 1101012 SU-1012-A 1101015 SU-1015-A 1101200 SU-1200-A 1101202 SU-1202-A 1101205 SU-1205-A 1101210 SU-1210-A 1101212 SU-1212-A 1101215 SU-1215-A 1107009 SU-7009-A 11070...
2109113 ST-9113-A 1101000 SU-1000-A 1101002 SU-1002-A 1101005 SU-1005-A 1101006 SU-1006-A 1101010 SU-1010-A 1101012 SU-1012-A 1101015 SU-1015-A 1101200 SU-1200-A 1101202 SU-1202-A 1101205 SU-1205-A 1101210 SU-1210-A 1101212 SU-1212-A 1101215 SU-1215-A 1107009 SU-7009-A 11070...
In certain embodiments, the pathogen antigen is a viral antigen present in Cytomegalovirus (CMV), a viral antigen present in Epstein Barr Virus (EBV), a viral antigen present in Human Immunodeficiency Virus (HIV), or a viral antigen present in influenza virus. 2.2. T-Cell Receptor (TCR) In...
Suitable antigens for use in the treatment of pathogen infection or other infectious disease, for example, in an immunocompromised subject include, without limitation, viral antigens present in Cytomegalovirus (CMV), Epstein Barr Virus (EBV), Human Immunodeficiency Virus (HIV), and influenza virus....
Chang et al., “A novel peptide enhances therapeutic efficacy of liposomal anti-cancer drugs in mice models of human lung cancer.” PLoS One, 4(1):e4171 (2009). Cole et al., “The EBV-hybridoma technique and its application to human lung cancer.” in Monoclonal Antibodies and Cancer ...
This assay is performed, in another embodiment, on live fresh or 0.25% paraformaldehyde-fixed human PBMC, leukemia cell lines and EBV-transformed T-cell lines of specific HLA types. The relative avidity of the peptides found to bind MHC molecules on the specific cells are assayed by ...